InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Bredt David. Director active across 1 company, notably Rapport Therapeutics, Inc.. Aggregated, 3 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €230k. History available since 14 March 2025. The latest transaction was filed on 15 May 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations